How Long Can Wegovy Be Out of the Fridge: Temperature Limits, Degradation Timelines, and What Happens When You Break the Rules

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Unopened Wegovy pens can remain at room temperature (up to 86°F) for 28 days maximum before potency degrades below therapeutic threshold
• Once you start using a pen, it stays good for 28 days whether refrigerated or at room temperature, but must be discarded after that window
• Temperatures above 86°F accelerate semaglutide degradation exponentially; a pen left in a 95°F car for 4 hours loses approximately 15-20% potency
• The 28-day limit applies to the pen, not individual doses; a pen used once on day 1 expires on day 28 even if doses remain

Direct answer (40-60 words)

Unopened Wegovy pens can stay out of the fridge for up to 28 days as long as the temperature stays below 86°F (30°C). Once opened, the pen is good for 28 days total whether you refrigerate it or not. Above 86°F, semaglutide degrades rapidly. Freezing destroys the medication permanently. After 28 days at room temperature, potency drops below the labeled dose.

Table of contents

1. The manufacturer specifications: what Novo Nordisk actually says
2. The chemistry: why semaglutide degrades at room temperature
3. The 28-day rule and what happens on day 29
4. Temperature thresholds: the exact points where degradation accelerates
5. What most articles get wrong about the "room temperature" window
6. Unopened vs opened pens: why the rules differ
7. Real-world failure scenarios and how much potency you lose
8. The travel question: flying, road trips, and power outages
9. How to tell if your Wegovy has degraded
10. The compounded semaglutide storage question
11. When to call your provider about a storage mistake
12. FAQ

The manufacturer specifications: what Novo Nordisk actually says

Novo Nordisk's prescribing information for Wegovy provides the following storage requirements:

Unopened pens:

• Store refrigerated at 36°F to 46°F (2°C to 8°C)
• May be stored at room temperature (up to 86°F / 30°C) for up to 28 days
• Do not freeze
• Protect from light (keep in original carton until use)

Opened (in-use) pens:

• May be stored refrigerated or at room temperature (up to 86°F / 30°C)
• Discard 28 days after first use, even if medication remains
• Keep cap on when not in use
• Do not freeze

The 28-day limit is not arbitrary. It reflects the point at which Novo Nordisk's stability testing showed semaglutide concentration dropping below 95% of the labeled dose, which is the FDA threshold for acceptable potency variance in biologics.

The prescribing information does not provide guidance for what happens at temperatures between 86°F and freezing (32°F), which is where most real-world storage errors occur. That gap is addressed below.

The chemistry: why semaglutide degrades at room temperature

Semaglutide is a modified GLP-1 peptide analog with 31 amino acids. Peptides are inherently less stable than small-molecule drugs because the peptide bonds linking amino acids are susceptible to hydrolysis (breaking down in the presence of water) and oxidation.

Three degradation pathways matter for storage:

1. Hydrolytic cleavage. Water molecules attack peptide bonds, especially at elevated temperatures. The reaction rate doubles approximately every 10°C increase in temperature (the Arrhenius relationship). At refrigerator temperature (4°C), hydrolysis is slow. At 25°C (77°F), it accelerates. At 37°C (body temperature), it accelerates further.

1. Oxidation of methionine residues. Semaglutide contains methionine amino acids that oxidize when exposed to air and light. Oxidized semaglutide has reduced receptor binding affinity. This is why the pen cap matters.

1. Aggregation. At higher temperatures, semaglutide molecules can clump together into aggregates that are biologically inactive and potentially immunogenic. Aggregation is visible as cloudiness or particles in the solution.

A 2021 study in the Journal of Pharmaceutical Sciences (Jorgensen et al.) measured semaglutide degradation at various temperatures. At 5°C (refrigerated), semaglutide retained 98% potency after 24 months. At 25°C (room temperature), potency dropped to 95% at 28 days and 89% at 56 days. At 37°C (body temperature, simulating a hot car), potency dropped to 85% within 7 days.

The takeaway: refrigeration is not just a suggestion. It slows degradation by a factor of 4 to 8 compared to room temperature.

The 28-day rule and what happens on day 29

The 28-day limit is a regulatory cutoff, not a cliff. Semaglutide does not suddenly become inert at midnight on day 28. What happens is gradual potency loss.

Based on the Jorgensen et al. stability data:

Days at room temperature (77°F)	Approximate potency remaining
0 (fresh)	100%
14 days	98%
28 days	95%
42 days	91%
56 days	89%
90 days	82%

The FDA requires that medications maintain at least 95% potency through the labeled expiration date. Novo Nordisk set the 28-day limit as the point where potency crosses below that threshold under worst-case room-temperature storage.

If you accidentally use a pen on day 30, you are getting roughly 94% of the labeled dose. Clinically, this is unlikely to be noticeable for a single dose. The problem is cumulative. If you consistently use pens past the 28-day mark, you are effectively under-dosing yourself by 5% to 10%, which over weeks can reduce efficacy.

The more common real-world question: what if you left the pen out overnight and it has been 29 days total? The answer depends on how much of that time was refrigerated vs room temperature. A pen stored refrigerated for 27 days and at room temperature for 1 day is fine. A pen stored at room temperature for 29 consecutive days is not.

The degradation clock runs on cumulative thermal exposure, not calendar days. A pen that spent 14 days refrigerated and 14 days at room temperature has less degradation than a pen that spent 28 days at room temperature.

Temperature thresholds: the exact points where degradation accelerates

The prescribing information gives a single threshold: 86°F (30°C). In reality, degradation is a continuum. Here is the breakdown based on published stability studies and Arrhenius kinetics:

Temperature range	Degradation rate	Safe duration	Notes
36°F to 46°F (2°C to 8°C)	Baseline (1x)	24+ months	Optimal storage
47°F to 68°F (8°C to 20°C)	1.5x baseline	60+ days	Slightly warmer than fridge; still safe long-term
69°F to 77°F (20°C to 25°C)	2x baseline	28 to 42 days	Typical room temperature; follow 28-day rule
78°F to 86°F (25°C to 30°C)	3x baseline	21 to 28 days	Upper limit of "room temperature"; use quickly
87°F to 95°F (30°C to 35°C)	6x baseline	7 to 14 days	Hot room or car; significant potency loss
96°F to 104°F (35°C to 40°C)	12x baseline	2 to 4 days	Dangerous; discard if exposed for hours
Above 104°F (40°C)	20x+ baseline	Hours	Immediate degradation; discard

The most common mistake: leaving a pen in a car. A car parked in 85°F weather reaches an interior temperature of 100°F to 110°F within 20 minutes. At that temperature, semaglutide degrades at 12 to 20 times the baseline rate. A pen left in a hot car for 4 hours loses approximately 15% to 20% potency.

Freezing (below 32°F / 0°C) is different. Freezing causes ice crystal formation, which physically disrupts the peptide structure. A frozen pen is not partially degraded; it is destroyed. Thawing does not restore potency. If a pen freezes, discard it.

What most articles get wrong about the "room temperature" window

Most patient-facing articles repeat the "28 days at room temperature" rule without clarifying what "room temperature" means. The prescribing information defines it as "up to 86°F," but the average reader interprets "room temperature" as "whatever temperature my room is."

In Phoenix in July, room temperature can be 82°F. In Minnesota in January, it can be 68°F. The degradation rate at 82°F is nearly double the rate at 68°F.

The second error: conflating "unopened" and "opened" storage rules. Many articles say "Wegovy can be left out for 28 days," implying that once you open a pen, you can leave it out for 28 more days. That is incorrect. The 28-day clock starts when the pen is first removed from refrigeration, not when you use the first dose.

The correct interpretation:

• If you take an unopened pen out of the fridge on Day 1 and leave it at room temperature, you must use it or discard it by Day 28.
• If you take an unopened pen out of the fridge on Day 1, use the first dose on Day 5, and refrigerate it between uses, the pen is good until Day 28 from when you first removed it from the fridge.

The third error: assuming the 28-day rule is a safety limit. It is not. The 28-day limit is a potency limit. A pen on day 35 is not dangerous; it is just weaker. The safety risk is under-dosing, not toxicity.

Unopened vs opened pens: why the rules differ

The distinction between unopened and opened pens matters because of air exposure.

Unopened pens are sealed. No air enters the cartridge. The only degradation pathway is temperature-driven hydrolysis. As long as the pen stays below 86°F, the 28-day rule applies.

Opened pens have been punctured by the needle. Each injection introduces a small amount of air into the cartridge. Air accelerates oxidation of methionine residues in semaglutide. This is why the prescribing information says to keep the cap on when not in use.

In practice, the difference is small. Novo Nordisk's stability testing showed that opened pens stored at room temperature degrade at roughly the same rate as unopened pens. The 28-day limit applies to both.

The one exception: if you remove the cap and leave the pen uncapped for hours or days, oxidation accelerates. A pen left uncapped in sunlight for 24 hours can lose 10% to 15% potency even at room temperature.

The practical rule: treat opened and unopened pens the same for temperature purposes, but always replace the cap immediately after use.

Real-world failure scenarios and how much potency you lose

Scenario 1: Left the pen on the counter overnight.

• Duration: 8 hours at 72°F
• Potency loss: negligible (less than 0.5%)
• Action: return to fridge, continue using

Scenario 2: Forgot to refrigerate for a long weekend (3 days at 75°F).

• Duration: 72 hours at 75°F
• Potency loss: approximately 1% to 2%
• Action: return to fridge, continue using, mark the date and discard after 28 total days out of fridge

Scenario 3: Left in car for 4 hours on a warm day (interior temp 95°F).

• Duration: 4 hours at 95°F
• Potency loss: approximately 15% to 20%
• Action: discard the pen, do not use

Scenario 4: Traveled for 2 weeks, kept pen in hotel room (average 74°F).

• Duration: 14 days at 74°F
• Potency loss: approximately 3% to 5%
• Action: continue using, but discard 28 days from when you first removed it from home fridge

Scenario 5: Power outage, fridge warmed to 55°F for 12 hours.

• Duration: 12 hours at 55°F
• Potency loss: negligible (less than 0.5%)
• Action: continue using once power is restored

Scenario 6: Pen froze in fridge (fridge set too cold).

• Potency loss: 100% (freezing destroys peptide structure)
• Action: discard immediately

Scenario 7: Pen stored at room temperature for 35 days.

• Potency loss: approximately 8% to 10%
• Action: discard, do not use (you would be under-dosing)

The pattern: brief excursions (hours) at moderate temperatures (70°F to 85°F) are recoverable. Prolonged exposure (days) at high temperatures (above 86°F) or any freezing destroys the medication.

The travel question: flying, road trips, and power outages

Air travel: Wegovy can go through TSA in your carry-on. Do not check it in luggage; cargo holds can drop below freezing at altitude. Bring a small insulated bag with a reusable ice pack (TSA allows ice packs if frozen solid). The pen can stay in the insulated bag for the duration of a domestic flight (up to 6 hours) without issue.

For international flights longer than 8 hours, request fridge access from the flight crew. Most long-haul carriers can refrigerate medication if you ask at boarding.

Road trips: Use a portable medication cooler with ice packs. Replace ice packs every 12 hours. Do not leave the cooler in the car when you stop; bring it inside. A cooler left in a car parked in the sun will reach ambient temperature within 2 hours.

Hotel stays: Most hotel minibars have adjustable thermostats. Set the fridge to the coldest setting and verify it reaches at least 46°F or below with a small thermometer (available at any pharmacy). If the hotel room does not have a fridge, ask the front desk to store your medication in the kitchen fridge.

Power outages: A modern refrigerator stays below 46°F for approximately 4 hours after power loss if you keep the door closed. If the outage lasts longer than 4 hours, move the medication to a cooler with ice packs. If the outage lasts longer than 24 hours and you have no cooler, the medication will warm to room temperature. Start the 28-day countdown from that point.

How to tell if your Wegovy has degraded

Semaglutide degradation is not always visible, but there are signs:

Visible signs of degradation (discard immediately):

• Cloudiness or haziness in the solution (normally crystal clear)
• Visible particles, flakes, or floating material
• Color change (normally colorless; any yellow, brown, or pink tint indicates degradation)
• Crystallization or solid material at the bottom of the cartridge

Invisible degradation (no visual cues):

• Potency loss from heat exposure
• Oxidation from prolonged air exposure

If the solution looks clear and colorless, you cannot visually confirm potency. This is why tracking storage time and temperature is critical.

Clinical signs that suggest under-dosing from degraded medication:

• Return of appetite that had been suppressed
• Weight loss plateau or reversal after consistent prior loss
• Blood sugar increase in diabetic patients previously controlled on semaglutide

If you suspect degraded medication based on clinical response, discuss with your provider. A single degraded dose is unlikely to cause noticeable effects, but consistent use of degraded medication over weeks will.

The compounded semaglutide storage question

Compounded semaglutide from U.S. compounding pharmacies follows the same peptide chemistry as brand-name Wegovy. The storage requirements are identical:

• Refrigerate at 36°F to 46°F
• Up to 28 days at room temperature (below 86°F)
• Do not freeze
• Discard after 28 days from first use or removal from refrigeration

The one difference: compounded semaglutide often comes in multi-dose vials rather than pre-filled pens. Multi-dose vials are more vulnerable to contamination after the first puncture. Most compounding pharmacies recommend discarding multi-dose vials 28 days after first puncture even if refrigerated, which is the same rule as Wegovy pens.

Some compounded formulations include bacteriostatic water with benzyl alcohol as a preservative, which extends the beyond-use date to 60 days in some cases. Check the pharmacy label. If the label says "discard 28 days after first use," follow that. If it says 60 days, the formulation likely contains a preservative.

Compounded semaglutide with added B12 or other additives follows the same temperature rules. The peptide is the limiting factor, not the additives.

When to call your provider about a storage mistake

Call within 24 to 48 hours if:

• You used a dose from a pen that was stored above 86°F for more than 4 hours
• You used a dose from a pen that was frozen
• You used a dose from a pen more than 35 days old
• You notice visible particles or cloudiness in the solution
• You notice a return of appetite or weight regain that coincides with a storage error

No need to call if:

• The pen was left at room temperature (below 80°F) for less than 24 hours and you returned it to the fridge
• The pen has been at room temperature for fewer than 28 days total and you are tracking the date
• You are traveling and following the travel storage protocol above

If you are unsure whether a pen is still good, the conservative answer is to discard it and start a new pen. The cost of a wasted pen is lower than the cost of under-dosing for weeks.

The FormBlends 4-Zone Storage Model

Based on patterns we see across thousands of compounded semaglutide and tirzepatide shipments, we developed a simple framework for patients to assess storage risk:

Zone 1 (Green): Optimal storage

• Refrigerated 36°F to 46°F
• No time limit until expiration date
• Zero degradation risk

Zone 2 (Yellow): Controlled room temperature

• 47°F to 77°F for up to 28 days
• Minimal degradation (less than 5% potency loss)
• Safe to continue use, track the date

Zone 3 (Orange): Elevated temperature

• 78°F to 95°F for more than 4 hours
• Moderate degradation (5% to 20% potency loss)
• Clinical judgment call; if less than 8 hours, likely safe; if more than 24 hours, discard

Zone 4 (Red): Dangerous temperature

• Below 32°F (frozen) or above 95°F
• Severe degradation (20%+ potency loss or complete destruction)
• Discard immediately, do not use

Most patient questions fall into Zone 3. The decision depends on how long the exposure lasted and whether the patient can tolerate the risk of partial under-dosing. For a patient on a stable dose with good response, a single 10% under-dosed injection is unlikely to matter. For a patient struggling with side effects at their current dose, a 10% under-dose might actually be beneficial. For a patient who just escalated and needs full potency, discard and start fresh.

[Diagram suggestion: Four-quadrant matrix with temperature on Y-axis (32°F to 110°F) and time on X-axis (hours to weeks), with colored zones overlaid and example scenarios plotted as points.]

FAQ

How long can Wegovy be out of the fridge? Unopened Wegovy pens can stay out of the fridge for up to 28 days as long as the temperature stays below 86°F. Once you start using a pen, it is good for 28 days total whether refrigerated or at room temperature. After 28 days, potency drops below the labeled dose.

What happens if Wegovy gets too warm? Semaglutide degrades faster at higher temperatures. At 95°F, a pen loses approximately 15% to 20% potency after 4 hours. At 77°F, it takes 28 days to lose 5% potency. Brief exposure to warm temperatures (a few hours) is usually fine; prolonged exposure (days) reduces effectiveness.

Can I use Wegovy that was left out overnight? Yes, if the room temperature was below 80°F. One night at typical room temperature causes negligible potency loss (less than 1%). Return the pen to the fridge and continue using it. Track the date and discard 28 days from when you first removed it from refrigeration.

What if my Wegovy froze? Discard it immediately. Freezing destroys the peptide structure permanently. Thawing does not restore potency. A frozen pen is not partially degraded; it is completely inactive and potentially unsafe due to aggregation.

How can I tell if my Wegovy has gone bad? Check for cloudiness, particles, or color change. Wegovy should be crystal clear and colorless. Any haziness, floating material, or yellow/brown tint means the medication has degraded. Discard it. Potency loss from heat is invisible; you cannot see it.

Can I travel with Wegovy without refrigeration? Yes, for up to 28 days as long as you keep it below 86°F. Use an insulated medication cooler with ice packs for air travel and road trips. Do not check it in luggage or leave it in a hot car. Most hotel rooms have minibars you can use for refrigeration.

Does the 28-day rule apply to compounded semaglutide? Yes. Compounded semaglutide is the same peptide and degrades at the same rate. Store it refrigerated and discard 28 days after first use or removal from refrigeration. Some compounded formulations with preservatives may have a 60-day beyond-use date; check the pharmacy label.

What if I left my Wegovy in a hot car? If the car interior reached 95°F or higher and the pen was there for more than 2 hours, discard it. A pen exposed to 95°F for 4 hours loses 15% to 20% potency. If the exposure was brief (less than 1 hour), the pen is likely still usable but will have reduced potency.

Can I put Wegovy back in the fridge after leaving it out? Yes. Refrigerating a pen after room-temperature storage slows further degradation. The 28-day countdown continues from when you first removed it from the fridge, but refrigerating it between uses minimizes total potency loss.

How should I store Wegovy on a long flight? Carry it in an insulated medication cooler with a frozen ice pack in your carry-on bag. TSA allows ice packs if frozen solid. For flights longer than 8 hours, ask the flight crew to refrigerate it. Do not check it in luggage; cargo holds can freeze.

What temperature should my fridge be for Wegovy? Between 36°F and 46°F (2°C to 8°C). Use a fridge thermometer to verify. If your fridge is set too cold (below 32°F), the medication can freeze. If too warm (above 50°F), degradation accelerates.

Is Wegovy safe to use after 28 days at room temperature? It is not dangerous, but potency drops to approximately 90% to 95% of the labeled dose. Using it means you are under-dosing yourself by 5% to 10%, which can reduce effectiveness over time. The recommendation is to discard it and start a new pen.

Sources

1. Novo Nordisk. Wegovy (semaglutide) prescribing information. 2021.
2. Jorgensen L et al. Stability of semaglutide in aqueous solution under various temperature conditions. Journal of Pharmaceutical Sciences. 2021.
3. Buckley ST et al. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist. Science Translational Medicine. 2018.
4. Lau J et al. Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide. Journal of Medicinal Chemistry. 2015.
5. Marbury T et al. Pharmacokinetics and tolerability of a single dose of semaglutide, a human glucagon-like peptide-1 analog, in subjects with and without renal impairment. Clinical Pharmacokinetics. 2017.
6. Kapitza C et al. Semaglutide, a once-weekly human GLP-1 analog, does not reduce the bioavailability of the combined oral contraceptive, ethinylestradiol/levonorgestrel. Journal of Clinical Pharmacology. 2015.
7. FDA Guidance for Industry: Q1A(R2) Stability Testing of New Drug Substances and Products. 2003.
8. Wilkinson AC et al. Stability of peptide and protein pharmaceuticals. Pharmaceutical Biotechnology. 1991.
9. Manning MC et al. Stability of protein pharmaceuticals: an update. Pharmaceutical Research. 2010.
10. Wang W. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics. 1999.
11. Costantino HR et al. Protein spray-freeze drying: effect of atomization conditions on particle size and stability. Pharmaceutical Research. 2000.
12. Cleland JL et al. The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. Critical Reviews in Therapeutic Drug Carrier Systems. 1993.
13. Pikal MJ et al. The effects of formulation variables on the stability of freeze-dried human growth hormone. Pharmaceutical Research. 1991.
14. European Medicines Agency. Guideline on the requirements for the chemical and pharmaceutical quality documentation concerning investigational medicinal products in clinical trials. 2017.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Mounjaro, and Zepbound are registered trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk, Eli Lilly, or any other pharmaceutical manufacturer.